Halozyme Therapeutics Inc. (NASDAQ:HALO): The Most Important Numbers You Should Know
Halozyme Therapeutics Inc. (NASDAQ:HALO) shares fell to a low of $41.29 before closing at $41.41. Intraday shares traded counted 2.82 million, which was -171.28% lower